Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:562-568
Published online before print August 18, 2003, doi: 10.1161/01.HYP.0000088852.28814.E2
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
42/4/562    most recent
01.HYP.0000088852.28814.E2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Büssemaker, E.
Right arrow Articles by Brandes, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Büssemaker, E.
Right arrow Articles by Brandes, R. P.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2003;42:562.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Aged Spontaneously Hypertensive Rats Exhibit a Selective Loss of EDHF-Mediated Relaxation in the Renal Artery

Eckhart Büssemaker; Rüdiger Popp; Beate Fisslthaler; Christiana M. Larson; Ingrid Fleming; Rudi Busse; Ralf P. Brandes

From the Institut für Kardiovaskuläre Physiologie, Klinikum der J.W. Goethe-Universität, Frankfurt am Main, Germany.

Correspondence to Ralf P. Brandes, MD, Institut für Kardiovaskuläre Physiologie, Klinikum der J.W. Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany. E-mail r.brandes{at}em.uni-frankfurt.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Endothelium-dependent relaxation is frequently attenuated in hypertension. We hypothesized that the contribution of the endothelium-derived hyperpolarizing factor (EDHF) to the acetylcholine (ACh)-induced, endothelium-dependent relaxation is attenuated with aging in the renal artery of spontaneously hypertensive rats (SHR) compared with age-matched Wistar-Kyoto (WKY) rats. ACh-induced, NO-mediated relaxation was identical in young (8-week-old) WKY and SHR, whereas EDHF-mediated relaxations (assessed in the presence of N{omega}-nitro-L-arginine and diclofenac) were much more pronounced in SHR than WKY. KCl-induced relaxations were more pronounced in vessels from young WKY rats than from young SHR. The cytochrome P450 inhibitor sulfaphenazole significantly inhibited EDHF-mediated relaxation in vessels from young SHR but not WKY. Vessels from old (22 months) SHR exhibited a slightly reduced NO-mediated relaxation but a complete loss of EDHF-mediated responses. In contrast, aging did not affect EDHF-mediated responses in WKY. Moreover, ACh-induced hyperpolarization and resting membrane potential were decreased in old SHR but not in WKY. KCl-induced relaxation increased with age in WKY, whereas no response to KCl was recorded in arteries from aged SHR. In vessels from old WKY but not old SHR, mRNA expression of the Na-K-ATPase subunit {alpha}2 was increased by 2-fold compared with young animals. These data indicate that the increase in EDHF responses in renal arteries from aged WKY can be attributed to the release of K+ ions from the endothelium, whereas increased EDHF responses in renal arteries from young SHR can be attributed to a sulfaphenazole-sensitive cytochrome P450-dependent EDHF.


Key Words: endothelium • nitric oxide • acetylcholine • endothelium-derived factors • animal models of hypertension • renal artery


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Three different endothelium-derived vasodilators, prostacyclin, nitric oxide (NO), and the endothelium-derived hyperpolarizing factor (EDHF), play an important role in the control of local vascular tone.1 In hypertension, endothelium-dependent relaxation is attenuated (a phenomenon referred to as endothelial dysfunction) and contributes to the increased peripheral resistance.2,3 Moreover, treatment of hypertension improves endothelium-dependent relaxation by increasing the NO-mediated and the EDHF-mediated relaxation.4,5

Endothelial dysfunction in hypertension has been linked to a decrease in NO bioavailability reflecting the impaired generation of NO and/or the enhanced scavenging and inactivation of NO by oxygen-derived free radicals.6,7 The mechanisms leading to the attenuation of EDHF-mediated relaxations in hypertension are poorly understood but are reportedly unrelated to enhanced vascular oxidative stress.8 Part of the problem in addressing the factors affecting EDHF-mediated responses is that more than one EDHF may exist and that different hyperpolarizing mechanisms dominate in different arteries. There is a general consensus that EDHF-mediated effects are exquisitely sensitive to the combination of the K+-channel inhibitors charybdotoxin and apamin and that the EDHF-mediated relaxation involves the hyperpolarization of endothelial cells, the subsequent hyperpolarization of smooth muscle cells, and the closure of voltage-dependent Ca2+ channels.9 To date, three main mechanisms for EDHF-mediated hyperpolarization have been proposed. First, K+ ions, released from the endothelium through Ca2+-dependent K+ channels, can activate inwardly rectifying K+ channels10 or the Na-K-ATPase10 on vascular smooth muscle cells to evoke hyperpolarization.11 Alternatively, smooth muscle hyperpolarization may occur as a consequence of the spread of the endothelial cell hyperpolarization through myo-endothelial gap junctions.12 Finally, EDHF responses in some vessels are dependent on the activation of a cytochrome P450 epoxygenase and the generation of epoxyeicosatrienoic acids (EETs)13

The contribution of EDHF to endothelium-dependent relaxation varies between vascular beds and species. Whereas in large conduit vessels, such as the aorta, endothelium-dependent responses are selectively mediated by NO, EDHF is the predominant endothelium-dependent vasodilator in resistance vessels.14 In intermediate-sized vessels, such as coronary or the renal arteries, EDHF has been proposed to act as a backup system to maintain endothelial function in situations associated with a decreased bioactivity of NO.15,16 In the present study, we studied young (8 weeks) and old (22 months) spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto (WKY) rats to assess the effects of hypertension on the EDHF-mediated hyperpolarization and relaxation of renal arteries.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
An expanded Methods section can be found in an online supplement available at http://www.hypertensionaha.org.

Organ Chamber Experiments
Experiments were performed in phenylephrine-precontracted renal artery rings in the presence of diclofenac (10 µmol/L), as described.17 Cumulative concentration-relaxation curves were obtained to either acetylcholine (ACh, 1 nmol/L to 10 µmol/L) or KCl (4 to 10 mmol/L). EDHF-mediated responses were defined as that portion of the endothelium-dependent relaxation that remained in the presence of N{omega}-nitro-L-arginine (L-NA, 300 µmol/L) and diclofenac.

A table containing the values for maximal relaxation and half maximal effective concentration is provided in the online supplement.

Membrane Potential Recordings
The membrane potential of renal arteries was recorded with the use of sharp microelectrodes, as described.17

Real-Time PCR Analysis
Total RNA was isolated. After reverse transcription, the rat {alpha}1, {alpha}2, {alpha}3, and {gamma} subunits of the Na-K-ATPase were amplified by means of quantitative real-time PCR.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Endothelium-dependent relaxation to ACh was identical in renal artery rings from young SHR and WKY rats. Aging was associated with a significant rightward shift in the concentration-relaxation curve to ACh in both strains, although a more pronounced effect was detected in vessels from SHR (Figure 1A). Similar results were obtained when the experiments were performed in the presence of KCl (40 mmol/L) to prevent ACh-induced EDHF-mediated relaxations (Figure 1B).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Contribution of NO and EDHF to endothelium-dependent relaxation of renal arteries from young and old SHR and WKY rats. Concentration-relaxation curves to acetylcholine in renal artery rings from young (8 weeks, left panel) and old (22 months, right panel) SHR ({triangleup}) and WKY rats ({blacksquare}) preconstricted with phenylephrine in the presence of diclofenac (10 µmol/L). Experiments were performed A, in the absence of additional inhibitors to study the combined endothelium-dependent relaxation to ACh; B, in the presence of KCl (40 mmol/L) to assess NO-mediated relaxation; and C, in the presence of L-NA (300 µmol/L) to assess EDHF-mediated relaxations. Results are mean±SEM; analysis was performed with 2-way ANOVA for repeated measurements.

EDHF-mediated relaxations, recorded in the combined presence of L-NA and diclofenac, were more pronounced in renal artery rings from young SHR than from young WKY rats. In vessels from older animals, however, the situation was reversed. Although the dose-response curve of EDHF-mediated relaxations of renal arteries from WKY rats was only slightly shifted to the right, almost no EDHF-mediated relaxation could be detected in arteries from SHR (Figure 1C).

The resting membrane potential of renal artery smooth muscle cells was identical in vessels from young and old WKY as well as from young SHR but was significantly depolarized in vessels from old SHR. ACh-induced, EDHF-mediated hyperpolarizations were comparable in renal artery rings from young WKY rats and SHR. In accordance with the results of the organ chamber experiments, EDHF-mediated hyperpolarizations were not markedly altered in vessels from old WKY rats but were significantly reduced in renal arteries from old SHR rats (Figure 2).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. Smooth muscle membrane potential in renal arteries from young and old SHR and WKY rats. Resting membrane potential (MP, upper panel) and acetylcholine (1 µmol/L) induced hyperpolarizations ({Delta}MP, lower panel) recorded in renal artery segments from young (8 weeks, left) and old (22 months, right) SHR and WKY rats in the presence of diclofenac (10 µmol/L), L-NA (300 µmol/L), and phenylephrine (30 nmol/L) to mimic conditions in the organ chamber experiments. Results are mean±SEM, *P<0.05 young vs old; #P<0.05 WKY vs SHR. Analysis was performed with 2-way ANOVA for repeated measurements.

To study the role of K+ ions and the Na-K-ATPase in EDHF-mediated responses, concentration-relaxation curves to KCl were performed, and the effect of the Na-K-ATPase inhibitor ouabain was determined. A low concentration of ouabain (50 µmol/L) had no effect on the EDHF-mediated relaxation of vessels from young animals, whereas 500 µmol/L ouabain, which induced a marked depolarization of the vessel (data not shown), almost completely inhibited EDHF-mediated relaxations (Figures 3A and 3B). KCl relaxed renal artery rings from young WKY, an effect that was sensitive to low concentrations of ouabain. In contrast, KCl had a negligible effect on the tone of rings from young SHR (Figures 3C and 3D). Accordingly, KCl-induced hyperpolarizations were significantly more pronounced in renal arteries from young WKY rats than from young SHR (Figure 3E). Ouabain (500 µmol/L) significantly inhibited the hyperpolarizations induced by ACh and KCl (Figure 3F).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 3. Characterization of vascular responses in renal arteries from young SHR and WKY rats: A and B, Comparison of effects of solvent ({blacksquare}, {triangleup}) with those of low ({square}, {blacktriangleup}, 50 µmol/L) and high ({blacklozenge}, {diamond}, 500 µmol/L) concentrations of ouabain on the acetylcholine-induced EDHF-mediated relaxation of renal artery rings from (A) young WKY rats and (B) SHR. C and D, Concentration-relaxation curves to KCl of endothelium-intact renal artery rings preconstricted with phenylephrine in the absence (C) and presence (D) of a low concentration of ouabain (50 µmol/L). E, Change in smooth muscle membrane potential ({Delta}MP) induced by bolus application of KCl (end concentration, 10 mmol/L) to renal artery rings from WKY rats (black bars) and SHR (white bars). F, Effect of ouabain (Oub, 50 µmol/L, shaded bars) on acetylcholine (ACh)- and KCl-induced hyperpolarization of renal artery smooth muscle from WKY rats. A through F, All experiments were performed in the continuous presence of diclofenac (10 µmol/L) and L-NA (300 µmol/L). Results are mean±SEM, *P<0.05. Analyses were performed with (A through D) 2-way ANOVA for repeated measurements; E, 2-tailed unpaired t test; F, 2-way ANOVA.

To assess the mechanism(s) underlying the more pronounced but potassium-independent EDHF-mediated responses in renal arteries from young SHR, different EDHF pathways were studied by using specific inhibitors. A moderate concentration of catalase (1200 U/mL) had no effect on EDHF-mediated relaxation in vessels from either strain (data not shown). Blockade of gap junctions, using specific connexin-blocking peptides (GAP peptide) according to combinations and concentrations reported recently by others,18,19 failed to attenuated the differences in the EDHF-mediated response between the two strains (data not shown). Specific inhibition of cytochrome P450 CYP 2C epoxygenases20 using sulfaphenazole (10 µmol/L) selectively attenuated EDHF-mediated relaxations in renal artery rings from SHR (Figure 4A). In the presence of sulfaphenazole, EDHF-mediated responses in young SHR and WKY were virtually superimposable. In contrast, 17-ODYA (10 µmol/L), which preferentially blocks CYP 4A isoforms, had no effect on the relaxation of rings from either strain (Figure 4B). The non–isoform-selective CYP-inhibitor miconazole (3 µmol/L), which is also known to block potassium channels,21,22 attenuated relaxations in vessels from WKY as well as SHR (Figure 4C).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. Effect of cytochrome P450 inhibitors on acetylcholine-induced, EDHF-mediated relaxation of renal arteries from young WKY rats and SHR: Effect of A, sulfaphenazole (10 µmol/L); B, 17-octadecynoid acid (ODYA, 10 µmol/L,); and C, miconazole (3 µmol/L) on acetylcholine-induced EDHF-mediated relaxation of renal artery rings from young WKY rats and SHR. All experiments were performed in the continuous presence of diclofenac (10 µmol/L) and L-NA (300 µmol/L). Results are mean±SEM. Analyses were performed by paired t test of the area under the curve.

In contrast to the observations made using vessels from young rats, a low concentration of ouabain (50 µmol/L) inhibited ACh-induced EDHF-mediated relaxations in renal arteries from 22-month-old animals (Figures 5A and 5B). Compared with arteries from young WKY rats, the hyperpolarization and relaxation elicited by KCl increased on aging (see Figures 3C and 5DownC). In contrast, in renal artery rings from old SHR, KCl failed to elicit either hyperpolarization or relaxation (Figures 5C and 5D). Relaxation in response to the K+-channel openers 1-EBIO and cromakalim were identical in renal artery rings from old WKY rats and SHR (Figures 5E and 5F).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 5. Characterization of vascular responses in renal arteries from aged SHR and WKY rats. A and B, Effect of low concentration of ouabain (50 µmol/L) on acetylcholine-induced, EDHF-mediated relaxation of renal artery rings from A, old WKY rats, and B, SHR. C, Concentration-relaxation curves to KCl in endothelium-intact renal artery rings from WKY rats ({blacksquare}) and SHR ({triangleup}). D, Change in smooth muscle membrane potential ({Delta}MP) induced by the bolus application of KCl (end concentration, 10 mmol/L) to renal artery rings from WKY rats (black bars) and SHR (white bars). E and F, Concentration-relaxation curves to the K+ channel openers 1-EBIO (E) and cromakalim (F) in renal artery rings from old WKY rats ({blacksquare}) and SHR ({triangleup}). A through F, All experiments were performed in the continuous presence of diclofenac (10 µmol/L) and L-NA (300 µmol/L). Results are mean±SEM, *P<0.05. Analyses were performed with 1-way ANOVA for repeated measurements (A through C, E and F) and 2-tailed t test (D).

With the use of real-time RT-PCR, the expression of mRNA encoding the {alpha}1, {alpha}2, {alpha}3, and {gamma} subunits of the Na-K-ATPase was assessed in renal arteries from WKY rats and SHR. In arteries from young animals, there were no clear strain-dependent differences in Na-K-ATPase subunit expression. Aging was associated with a marked increase in the expression of the {alpha}1-subunit in arteries from both strains. In contrast, the expression of the {alpha}2-subunit was exclusively increased in arteries from WKY rats. No differences in the expression of the {gamma}-subunit in vessels from young or old rats of either strain were observed (Figure 6). The {alpha}3-subunit, which was expressed at high levels in the rat brain, was not detectable in the renal artery (data not shown).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 6. mRNA expression of the Na-K-ATPase subunits {alpha}1, {alpha}2, {alpha}3, and {gamma} in rat femoral arteries from SHR and WKY. Top, Results of quantitative real-time RT-PCR demonstrating expression of mRNA encoding {alpha}1, {alpha}2, and {gamma} subunits of the Na-K-ATPase subunits in femoral arteries from young and old WKY rats and SHR. Na-K-ATPase signals were normalized to elongation factor 2 (EF2) signal and are expressed relative to the level observed in young rats of the respective strain. Results are mean±SEM, n=5 in each group, *P<0.05 old vs young. Analysis was performed with the 2-tailed t test. Bottom, Representative ethidium bromide–stained DNA gel showing Na-K-ATPase subunit expression in samples of rat renal artery (s), rat brain as positive control (pc). A negative control (nc) consisting of water and mRNA but without reverse transcriptase was included in each experiment.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In the present study, we observed pronounced differences in EDHF-mediated and KCl-induced responses in renal arteries from young and old WKY rats and SHR. Although EDHF-mediated responses were prominent in young SHR and were partially inhibited by the cytochrome P450 2C inhibitor sulfaphenazole, they were lost during aging. In contrast, in arteries from WKY rats, EDHF-mediated responses, which were initially resistant to inhibition of the Na-K-ATPase, became ouabain-sensitive with age. A phenomenon that was associated with an increase in the expression of the {alpha}2 subunit of the Na-K-ATPase.

Aging has previously been linked to the attenuation endothelium-dependent relaxation in arteries from SHR, and this phenomenon has been attributed to both a decrease in the bioavailability of NO as well as a decrease in the generation of an EDHF.4,5,23–25 Although NO-mediated responses are relatively easy to evaluate, the main difficulty in investigating alterations in EDHF-mediated relaxations is related to the fact that different types of EDHF appear to exist and indeed may act in parallel. Currently, the only feature shared by all of the EDHFs described is the exquisite sensitivity of responses to the combination of charybdotoxin and apamin. This is thought to reflect the importance of the opening of Ca2+-dependent K+ channels in endothelial cells.26 The efflux of K+ ions through Ca2+-dependent K+ channels has been suggested to result in a sufficient increase in the subendothelial K+ concentration to activate inwardly rectifying K+ channels and/or the Na-K-ATPase in smooth muscle cells.10,27–29 There are, however, other means of transferring hyperpolarization from one cell type to another. For example, hyperpolarizing factor(s) such as EETs could be released from endothelial cells. Although it was initially suggested that EETs may act as diffusible hyperpolarizing factors, these lipid mediators may rather influence the magnitude of the endothelial cell hyperpolarization; which is the initial step in the generation of EDHF-mediated responses.9 Endothelial cell hyperpolarization could also spread electrotonically from endothelial to vascular smooth muscle cells through myo-endothelial gap junctions,30 thereby inducing an endothelium-driven hyperpolarization of smooth muscle cells.31,32 Gap junctional communication as well as the activation of inwardly rectifying K+ channels and the Na-K-ATPase have all been shown to simultaneously contribute to the EDHF phenomenon in isolated rat vessels.18,33,34 However, only the activation of inwardly rectifying K+ channels and the Na-K-ATPase are dependent on an increase in the subendothelial concentration of K+ ions and can therefore be mimicked by the direct application of KCl.

A comparison of the responses of renal arteries from young and old SHR and WKY rats revealed that only vessels from the latter strain responded to exogenously applied KCl with a pronounced hyperpolarization and relaxation. Thus, it appears that the EDHF phenomenon in renal arteries from SHR is unrelated to the activation of the Na-K-ATPase or the inwardly rectifying K+ channels. Although such observations may indirectly imply a potential role for gap junctions in EDHF-mediated responses in these animals, it was not possible to selectively block EDHF-mediated relaxation in the renal artery of SHR using specific connexin blocking peptides (gap peptides). Moreover, EDHF-mediated responses in renal arteries from SHR were markedly less sensitive to the gap peptides than were vessels from WKY rats (Büssemaker, unpublished observations). Although cytochrome P450 epoxygenases play a crucial role in EDHF-mediated responses in some species, several studies,35,36 including one performed using rat renal arteries,37 have reported that the EDHF-mediated relaxation of vessels from WKY and Sprague-Dawley rats does not require the activation of a cytochrome P450 enzyme. Cytochrome P450 epoxygenases can, however, be induced by several pathways associated with the induction of hypertension. For example, dietary salt loading increases cytochrome P450 expression in the kidney,38 and EET production is reported to be higher in renal arteries from SHR than in the same vessels from WKY rats.39 In the present study, two cytochrome P450 inhibitors, the non–isoform-selective epoxygenase inhibitor miconazole and the selective 2C9 inhibitor sulfaphenazole, attenuated EDHF-mediated responses in arteries from SHR. In contrast, a cytochrome P450 inhibitor that preferentially blocks the {omega}-hydroxylase was without effect. Miconazole, however, also attenuated the maximal EDHF-mediated relaxation in arteries from WKY rats, an effect that may be due to the nonspecific inhibition of K+ channels which has been reported as a side effect of some cytochrome P450 inhibitors.21,22 Taken together, these observations suggest that a major difference in the EDHF-mediated responses recorded in renal arteries from young SHR and WKY rats can be attributed to the differential involvement of a cytochrome P450 epoxygenase that is sensitive to sulfaphenazole

In contrast to the situation in SHR, the magnitude of EDHF-mediated responses in renal arteries from WKY rats were not affected by aging. There was, however, a marked age-dependent alteration in the sensitivity of the EDHF to a low concentration of the Na-K-ATPase inhibitor ouabain (50 µmol/L). Because much higher concentrations of ouabain are required to inhibit the {alpha}1 subunit of the Na-K-ATPase, these data suggest that the age-dependent alteration in EDHF-mediated responses can be attributed to a change in the {alpha}2 or {alpha}3 subunits of the Na-K-ATPase.40 Indeed, using quantitative RT-PCR, we detected a significant, age-dependent increase in the expression of mRNA encoding the {alpha}2 subunit in vessels from WKY rats. No such effect was detected in arteries from SHR. Although such observations correlate well with the functional studies, these data should be interpreted with caution, since limitations associated with tissue availability meant that Na-K-ATPase expression was assessed in femoral arteries. Thus, although renal and femoral arteries are similar in size, we cannot exclude that differences exist in the regulation of Na-K-ATPase subunit expression. It would also be important to confirm the results of the RT-PCR experiments at the protein level, since the activity of the Na-K-ATPase is largely determined by posttranscriptional mechanisms, including subcellular translocation and phosphorylation.41,42 Unfortunately, expression of Na-K-ATPase protein in isolated arteries was too low to be assessed by Western blot analysis, and commercially available antibodies failed to label specific proteins in preparations obtained with the use of different extraction methods, although all of the antibodies tested detected the Na-K-ATPase in extracts of rat brain and human umbilical vein endothelial cells (authors’ unpublished observations, 2002).

Our observation that the expression of the {alpha}1 subunit of the Na-K-ATPase increases with age in arteries from both SHR and WKY rats is in agreement with two previous studies using skeletal muscle from SHR.43,44 Although the altered expression of the {alpha}1 subunit could potentially influence membrane potential, the resting membrane potential was not altered in vessels from old WKY rats and was even decreased in arteries from SHR. Neither of these effects appear to be compatible with the enhanced activation of the Na-K-ATPase.

In light of the marked KCl-induced relaxation and hyperpolarization as well as the ouabain insensitivity of the ACh-induced relaxation, it could be speculated that the EDHF-mediated responses observed in arteries from young WKY can be attributed to the activation of the inwardly rectifying K+ channels. However, a concentration of barium far exceeding that required to specifically block this channel11 was needed to attenuate EDHF-mediated relaxations in arteries from young WKY rats (Christiana M. Larson, unpublished observations, 2003).

In conclusion, our results demonstrate that the mechanisms underlying EDHF-mediated responses in renal arteries from SHR and WKY rats are distinct. The aging-induced attenuation of EDHF-mediated responses in SHR is most probably the consequence of the loss of a K+ ion-independent pathway, involving cytochrome P450 epoxygenases, whereas the increase in EDHF-mediated responses in arteries from WKY rats appears to be the consequence of an increase in the expression of the {alpha}2 subunit of the Na-K-ATPase.


*    Acknowledgments
 
This study was supported by the Deutsche Gesellschaft für Kardiologie–Herz und Kreislaufforschung and the Else Kröner-Fresenius-Stiftung (E.B.) and a research grant from the Institut de Recherches Internationales Servier. We are indebted to Sina Bätz and Ingrid Kempter for excellent technical assistance.

Received June 27, 2003; first decision July 15, 2003; accepted July 18, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Bassenge E. Control of coronary blood flow by autacoids. Basic Res Cardiol. 1995; 90: 125–141.[CrossRef][Medline] [Order article via Infotrieve]

2. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990; 323: 22–27.[Abstract]

3. Lüscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertens Suppl. 1994; 12: S105–S116.[Medline] [Order article via Infotrieve]

4. Kahonen M, Tolvanen JP, Kalliovalkama J, Wu X, Karjala K, Makynen H, Porsti I. Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats. Eur J Pharmacol. 1999; 368: 213–222.[CrossRef][Medline] [Order article via Infotrieve]

5. Onaka U, Fujii K, Abe I, Fujishima M. Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats. Circulation. 1998; 98: 175–182.[Abstract/Free Full Text]

6. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996; 97: 1916–1923.[Medline] [Order article via Infotrieve]

7. Kojda G, Harrison DG. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Research. 1999; 43: 562–571.[CrossRef][Medline] [Order article via Infotrieve]

8. Kaw S, Hecker M. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery. Naunyn Schmiedebergs Arch Pharmacol. 1999; 359: 133–139.[CrossRef][Medline] [Order article via Infotrieve]

9. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharamcol Sci. 2002; 23: 374–380.[CrossRef][Medline] [Order article via Infotrieve]

10. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396: 269–216.[CrossRef][Medline] [Order article via Infotrieve]

11. Knot HJ, Zimmermann PA, Nelson MT. Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. J Physiol (London). 1996; 492: 419–430.[Abstract/Free Full Text]

12. Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol (London). 1998; 508: 561–573.[Abstract/Free Full Text]

13. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999; 401: 493–497.[CrossRef][Medline] [Order article via Infotrieve]

14. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A. 2000; 97: 9747–9752.[Abstract/Free Full Text]

15. Brandes RP, Behra A, Lebherz C, Böger RH, Bode-Böger SM, Mügge A. N{omega}nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis. 1997; 135: 49–55.[CrossRef][Medline] [Order article via Infotrieve]

16. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996; 94: 3341–3347.[Abstract/Free Full Text]

17. Büssemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, Brandes RP. Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovasc Res. 2003; 59: 181–188.[CrossRef][Medline] [Order article via Infotrieve]

18. Chaytor AT, Martin PE, Edwards DH, Griffith TM. Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. Am J Physiol. 2001; 280: H2441–H2450.

19. Sandow SL, Bramich NJ, Bandi HP, Rummery NM, Hill CE. Structure, function, and endothelium-derived hyperpolarizing factor in the caudal artery of the SHR and WKY rat. Arterioscler Thromb Vasc Biol. 2003; 23: 822–828.[Abstract/Free Full Text]

20. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001; 88: 44–51.[Abstract/Free Full Text]

21. Vanheel B, Calders P, Van dB, I, Van d, V. Influence of some phospholipase A2 and cytochrome P450 inhibitors on rat arterial smooth muscle K+ currents. Can J Physiol Pharmacol. 1999;77:481–489.

22. Hernandez-Benito MJ, Macianskiene R, Sipido KR, Flameng W, Mubagwa K. Suppression of transient outward potassium currents in mouse ventricular myocytes by imidazole antimycotics and by glybenclamide. J Pharmacol Exp Ther. 2001; 298: 598–606.[Abstract/Free Full Text]

23. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, Fujishima M. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992; 70: 660–669.[Abstract/Free Full Text]

24. Fujii K, Ohmori S, Tominaga M, Abe I, Takata Y, Ohya Y, Kobayashi K, Fujishima M. Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol. 1993; 265: H509–H516.[Medline] [Order article via Infotrieve]

25. Mantelli L, Amerini S, Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol. 1995; 25: 595–602.[Medline] [Order article via Infotrieve]

26. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995; 16: 23–30.[CrossRef][Medline] [Order article via Infotrieve]

27. Edwards G, Gardener MJ, Feletou M, Brady G, Vanhoutte PM, Weston AH. Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol. 1999; 128: 1064–1070.[CrossRef][Medline] [Order article via Infotrieve]

28. Richards GR, Weston AH, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. Suppression of K(+)-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol. 2001; 134: 1–5.[CrossRef][Medline] [Order article via Infotrieve]

29. Weston AH, Richards GR, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. K(+)-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na(+)/K(+)-ATPases. Br J Pharmacol. 2002; 136: 918–926.[CrossRef][Medline] [Order article via Infotrieve]

30. Emerson GG, Segal SS. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: role in vasomotor control. Circ Res. 2000; 87: 474–479.[Abstract/Free Full Text]

31. Spagnoli LG, Villaschi S, Neri L, Palmieri G. Gap junctions in myo-endothelial bridges of rabbit carotid arteries. Experientia. 1982; 38: 124–125.[CrossRef][Medline] [Order article via Infotrieve]

32. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002; 90: 1108–1113.[Abstract/Free Full Text]

33. Edwards G, Feletou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol. 1999; 128: 1788–1794.[CrossRef][Medline] [Order article via Infotrieve]

34. Harris D, Martin PE, Evans WH, Kendall DA, Griffith TM, Randall MD. Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K(+)-relaxation. Eur J Pharmacol. 2000; 402: 119–128.[CrossRef][Medline] [Order article via Infotrieve]

35. Zygmunt PM, Edwards G, Weston AH, Davis SC, Högestätt ED. Effects of cytochrome P450-inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br J Pharmacol. 1996; 118: 1147–1152.[Medline] [Order article via Infotrieve]

36. Fulton D, McGiff JC, Wolin MS, Kaminski P, Quilley J. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat. J Pharmacol Exp Ther. 1997; 280: 702–709.[Abstract/Free Full Text]

37. Jiang F, Li CG, Rand MJ. Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries. Br J Pharmacol. 2000; 130: 1191–1200.[CrossRef][Medline] [Order article via Infotrieve]

38. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest. 1999; 104: 751–760.[Medline] [Order article via Infotrieve]

39. Pomposiello SI, Carroll MA, Falck JR, McGiff JC. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR. Hypertension. 2001; 37: 887–893.[Abstract/Free Full Text]

40. O’Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys. 1994; 310: 32–39.[CrossRef][Medline] [Order article via Infotrieve]

41. Ewart HS, Klip A. Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995; 269: C295–C311.[Medline] [Order article via Infotrieve]

42. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol. 1998; 275: F633–F650.[Medline] [Order article via Infotrieve]

43. Carlsen RC, Gray SD, Pickar JG. Na+, K(+)-pump activity and skeletal muscle contractile deficits in the spontaneously hypertensive rat. Acta Physiol Scand. 1996; 156: 237–245.[CrossRef][Medline] [Order article via Infotrieve]

44. Pickar JG, Atrakchi A, Gray SD, Carlsen RC. Apparent upregulation of Na+, K+ pump sites in SHR skeletal muscle with reduced transport capacity. Clin Exp Hypertens A. 1991; 13: 645–652.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Ponnuchamy and R. A. Khalil
Cellular mediators of renal vascular dysfunction in hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1001 - R1018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. G. Denniss and J. W. E. Rush
Impaired hemodynamics and endothelial vasomotor function via endoperoxide-mediated vasoconstriction in the carotid artery of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1038 - H1047.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. M. Vanhoutte and E. H. C. Tang
Endothelium-dependent contractions: when a good guy turns bad!
J. Physiol., November 15, 2008; 586(22): 5295 - 5304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Tang, N. Aggarwal, B. B. Holmes, H. Kuhn, and W. B. Campbell
Age-related decrease in 15-lipoxygenase contributes to reduced vasorelaxation in rabbit aorta
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H679 - H687.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. L. Gaubert, D. Sigaudo-Roussel, M. Tartas, G. Berrut, J. L. Saumet, and B. Fromy
Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice
J. Physiol., December 1, 2007; 585(2): 617 - 626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhao, J. E. Quigley, J. Yuan, M.-H. Wang, Y. Zhou, and J. D. Imig
PPAR-{alpha} activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2187 - H2195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Bellien, R. Joannides, M. Iacob, P. Arnaud, and C. Thuillez
Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1347 - H1352.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes, I. Fleming, and R. Busse
Endothelial aging
Cardiovasc Res, May 1, 2005; 66(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. D. Taylor, I. Y. Khan, M. A. Hanson, and L. Poston
Impaired EDHF-mediated vasodilatation in adult offspring of rats exposed to a fat-rich diet in pregnancy
J. Physiol., August 1, 2004; 558(3): 943 - 951.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
42/4/562    most recent
01.HYP.0000088852.28814.E2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Büssemaker, E.
Right arrow Articles by Brandes, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Büssemaker, E.
Right arrow Articles by Brandes, R. P.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Endothelium/vascular type/nitric oxide